Financials
| Q3 Trading Update | Apr. 10, 2025 |
| Half-year Report | Mar. 18, 2025 |
| Trading Update | Jan. 27, 2025 |
| Audited Full Year Fiscal 2024 Results | Nov. 21, 2024 |
| Financial Results for Q1 of Fiscal Year 2025 | Nov. 20, 2024 |
| Audited US GAAP financial results | Oct. 01, 2024 |
| Renalytix Reports Financial Results for Q3 FY2024 | May. 15, 2024 |
Proxies
| Publication of Annual Report and Notice of AGM | Nov. 26, 2024 |
| Result of AGM | Dec. 15, 2023 |
| Publication of Annual Report 2023 & Notice of AGM | Nov. 17, 2023 |
| Result of AGM | Dec. 19, 2022 |
| Result of AGM | Dec. 17, 2021 |
Ownership Update
| Holding(s) in Company | Jun. 27, 2025 |
| Holding(s) in Company | Jun. 26, 2025 |
| Holding(s) in Company | May. 30, 2025 |
| Holding(s) in Company | May. 29, 2025 |
| Holding(s) in Company | May. 27, 2025 |
| Holding(s) in Company | May. 16, 2025 |
| Holding(s) in Company | Apr. 29, 2025 |
Announcements
| kidneyintelX.dkd data presented at ERA Congress | Jun. 17, 2025 |
| Growing collaboration with NYKHM | Jun. 03, 2025 |
| First use of KidneyIntelX in new CKD therapy trial | May. 20, 2025 |
| Late Breaking KidneyIntelX data show care impact | Apr. 16, 2025 |
| Notice of Interim Results & Investor Presentation | Mar. 12, 2025 |
| Publication in journal (JASN) for kidneyIntelX.dkd | Feb. 06, 2025 |
| Foreign Private Issuer re-qualification | Jan. 17, 2025 |